ESMO 2024: Targeting the Treatment Challenges of Small Cell Lung Cancer - Episode 1
Current Landscape of First-Line Treatment for Limited-Stage SCLC: Diagnostic Workup & Multidisciplinary Approaches
Panelists discuss how the current landscape of first-line treatment for limited-stage small cell lung cancer is shaped by various clinical factors that influence the diagnostic workup and management, emphasizing the importance of a multidisciplinary team approach in developing effective treatment plans for these patients.
Video Player is loading.
Video content above is prompted by the following:
- Briefly explore the current landscape of first-line treatmentfor limited-stage small cell lung cancer (LS-SCLC):
- What clinical factors influence the initial diagnostic workup and managementof patients with LS-SCLC?
- To what degree is a multidisciplinary team approach adopted when developing a treatment plan for patients with LS-SCLC?
Related Content:
